Momentum

An Event-Level Analysis of the Interpersonal Factors Associated with Condomless Anal Sex among Gay, Bisexual and other Men who have Sex with Men with Online-Met Partners

Condomless anal sex among gbMSM with partners met online is associated with a variety of interpersonal factors to be considered in health interventions.

An Event-Level Analysis of the Interpersonal Factors Associated with Condomless Anal Sex among Gay, Bisexual and other Men who have Sex with Men with Online-Met Partners Read More »

Estimating the Size of the gbMSM Population in Metro Vancouver, Canada, Using Multiple Methods and Diverse Data Sources

Evidence from British Columbia and elsewhere has demonstrated the expansion of access to antiretroviral HIV treatment (ART) can result in population-level reductions in HIV incidence. This is the concept behind the made-in-BC Treatment as Prevention strategy, or TasP, which aims to expand early HIV testing and treatment to improve patients’ health and curb the spread

Estimating the Size of the gbMSM Population in Metro Vancouver, Canada, Using Multiple Methods and Diverse Data Sources Read More »

Research Update: Canadian study shows changes in attitudes about treatment as prevention among HIV-positive and HIV-negative MSM

Biomedical research demonstrating the benefits of taking HIV treatment to prevent HIV transmission (known as treatment as prevention, or TasP) has developed substantially in recent years. We are now able to say with confidence that an HIV-positive person who takes antiretroviral treatment (ART) and maintains an undetectable viral load cannot pass HIV to a sexual

Research Update: Canadian study shows changes in attitudes about treatment as prevention among HIV-positive and HIV-negative MSM Read More »

Research Update: Canadian study shows changes in attitudes about treatment as prevention among HIV-positive and HIV-negative MSM

Gay, bisexual and other men who have sex with men (MSM) represent over half of people living with HIV in Canada, so this community stands to benefit from using TasP¨ as a highly effective strategy for HIV prevention.

Research Update: Canadian study shows changes in attitudes about treatment as prevention among HIV-positive and HIV-negative MSM Read More »

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below